Nutex Health PE Ratio 2016-2025 | NUTX
Current and historical p/e ratio for Nutex Health (NUTX) from 2016 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Nutex Health PE ratio as of August 22, 2025 is 8.09.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Nutex Health PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-08-22 | 92.40 | 7.77 | |
| 2025-03-31 | 47.03 | $11.89 | 3.96 |
| 2024-12-31 | 31.69 | $9.23 | 3.43 |
| 2024-09-30 | 21.70 | $-9.39 | 0.00 |
| 2024-06-30 | 5.95 | $-9.17 | 0.00 |
| 2024-03-31 | 14.39 | $-10.59 | 0.00 |
| 2023-12-31 | 27.00 | $-11.99 | 0.00 |
| 2023-09-30 | 30.38 | $-7.50 | 0.00 |
| 2023-06-30 | 63.24 | $-103.45 | 0.00 |
| 2023-03-31 | 151.50 | $-106.45 | 0.00 |
| 2022-12-31 | 285.00 | $-157.42 | 0.00 |
| 2022-09-30 | 225.00 | $-154.42 | 0.00 |
| 2022-06-30 | 483.75 | $-56.97 | 0.00 |
| 2022-03-31 | 615.00 | $-52.47 | 0.00 |
| 2021-12-31 | 618.00 | 0 | 0.00 |
| 2021-09-30 | 674.99 | 0 | 0.00 |
| 2021-06-30 | 435.00 | 0 | 0.00 |
| 2021-03-31 | 405.00 | $88.46 | 4.58 |
| 2020-12-31 | 202.50 | $52.47 | 3.86 |
| 2020-09-30 | 240.00 | $52.47 | 4.57 |
| 2020-06-30 | 240.00 | $52.47 | 4.57 |
| 2020-03-31 | 211.50 | $-35.98 | 0.00 |
| 2019-12-31 | 300.00 | 0 | 0.00 |
| 2019-09-30 | 225.00 | 0 | 0.00 |
| 2019-06-30 | 300.00 | 0 | 0.00 |
| 2019-03-31 | 195.00 | 0 | 0.00 |
| 2018-12-31 | 375.00 | $-1.50 | 0.00 |
| 2018-09-30 | 1065.00 | $-1.50 | 0.00 |
| 2018-06-30 | 1725.00 | $-1.50 | 0.00 |
| 2018-03-31 | 5205.00 | $-6.00 | 0.00 |
| 2017-12-31 | 3750.00 | $-4.50 | 0.00 |
| 2017-09-30 | 24750.00 | $-4.50 | 0.00 |
| 2017-06-30 | 7500.00 | $-3.00 | 0.00 |
| 2017-03-31 | 6750.00 | 0 | 0.00 |
| 2016-12-31 | 5250.00 | 0 | 0.00 |
| 2016-09-30 | 6750.00 | 0 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.534B | $0.480B |
| Nutex Health Inc. is a physician-led, technology-enabled healthcare services company. The Company's operating divisions include Hospital division and Population Health Management division. Hospital division implements and operates different health care models, including micro hospitals, specialty hospitals and hospital outpatient departments. Population Health Management division owns and operates provider networks such as Independent Physician Associations. Nutex Health Inc., formerly known as Clinigence Holdings Inc., is based in HOUSTON. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $146.003B | 27.08 |
| CVS Health (CVS) | United States | $90.597B | 11.27 |
| Elevance Health (ELV) | United States | $69.715B | 9.38 |
| Cencora (COR) | United States | $58.790B | 19.58 |
| DiDi Global (DIDIY) | China | $29.369B | 31.20 |
| Labcorp Holdings (LH) | United States | $22.982B | 18.27 |
| Natera (NTRA) | United States | $22.227B | 0.00 |
| BioMerieux (BMXMF) | France | $17.547B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $15.490B | 0.00 |
| ICON (ICLR) | Ireland | $14.189B | 13.65 |
| Medpace Holdings (MEDP) | United States | $12.736B | 33.71 |
| CochLear (CHEOY) | Australia | $12.699B | 0.00 |
| Solventum (SOLV) | United States | $12.484B | 12.88 |
| Viatris (VTRS) | United States | $12.463B | 4.44 |
| Caris Life Sciences,�Inc (CAI) | United States | $10.720B | 0.00 |
| Revvity (RVTY) | United States | $10.408B | 18.34 |
| Avantor (AVTR) | United States | $8.563B | 12.56 |
| Sonic Healthcare (SKHHY) | Australia | $7.992B | 0.00 |
| HealthEquity (HQY) | United States | $7.874B | 34.49 |
| Charles River Laboratories (CRL) | United States | $7.606B | 14.43 |
| Bausch + Lomb (BLCO) | Canada | $5.133B | 34.52 |
| Sotera Health (SHC) | United States | $4.525B | 25.29 |
| BrightSpring Health Services (BTSG) | United States | $4.244B | 32.38 |
| KindlyMD (NAKA) | United States | $3.998B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $3.937B | 21.83 |
| GeneDx Holdings (WGS) | United States | $3.468B | 79.42 |
| Alignment Healthcare (ALHC) | United States | $3.129B | 0.00 |
| Concentras Parent (CON) | United States | $2.949B | 18.71 |
| Surgery Partners (SGRY) | United States | $2.931B | 36.87 |
| Organon (OGN) | United States | $2.412B | 2.63 |
| Premier (PINC) | United States | $2.106B | 19.53 |
| Progyny (PGNY) | United States | $1.989B | 42.06 |
| Ardent Health (ARDT) | United States | $1.826B | 7.05 |
| PACS (PACS) | United States | $1.788B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.560B | 26.41 |
| Pediatrix Medical (MD) | United States | $1.406B | 9.39 |
| Teladoc Health (TDOC) | United States | $1.270B | 0.00 |
| Omada Health (OMDA) | $1.236B | 0.00 | |
| Establishment Labs Holdings (ESTA) | $1.159B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.962B | 0.00 |
| Embecta (EMBC) | United States | $0.809B | 4.74 |
| AMN Healthcare Services Inc (AMN) | United States | $0.753B | 9.31 |
| CareDx (CDNA) | United States | $0.666B | 12.27 |
| QDM (QDMI) | Hong Kong, SAR China | $0.641B | 110.00 |
| Performant Healthcare (PHLT) | United States | $0.602B | 0.00 |
| Agilon Health (AGL) | United States | $0.510B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.484B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.466B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.465B | 6.98 |
| SBC Medicals (SBC) | United States | $0.438B | 9.61 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.414B | 0.00 |
| Enhabit (EHAB) | United States | $0.405B | 26.63 |
| So-Young (SY) | China | $0.395B | 0.00 |
| Oncology Institute (TOI) | United States | $0.329B | 0.00 |
| LifeMD (LFMD) | United States | $0.298B | 0.00 |
| Beauty Health (SKIN) | United States | $0.263B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.186B | 0.00 |
| DocGo (DCGO) | United States | $0.156B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.135B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.090B | 0.00 |
| Biodesix (BDSX) | United States | $0.062B | 0.00 |
| NeueHealth (NEUE) | United States | $0.059B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.051B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.038B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.035B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.022B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.013B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.012B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| OSR Holdings (OSRH) | United States | $0.010B | 0.00 |
| ModivCare (MODV) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| INVO Fertility (IVF) | United States | $0.005B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |